GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,871,000 | +11.6% | 111,904 | +11.7% | 0.34% | +13.0% |
| Q1 2022 | $4,363,000 | +48.4% | 100,150 | +50.2% | 0.30% | +32.6% |
| Q4 2021 | $2,940,000 | +64.0% | 66,670 | +42.1% | 0.23% | +23.4% |
| Q3 2021 | $1,793,000 | +135.9% | 46,918 | +145.7% | 0.18% | +100.0% |
| Q2 2021 | $760,000 | +182.5% | 19,095 | +153.5% | 0.09% | +91.7% |
| Q1 2021 | $269,000 | -64.3% | 7,534 | -63.2% | 0.05% | -75.9% |
| Q4 2020 | $754,000 | +17.8% | 20,493 | +20.6% | 0.20% | -18.8% |
| Q3 2020 | $640,000 | +15.3% | 16,992 | +25.0% | 0.24% | -22.5% |
| Q2 2020 | $555,000 | +51.6% | 13,598 | +40.7% | 0.32% | +3.3% |
| Q1 2020 | $366,000 | +15.5% | 9,665 | +43.5% | 0.31% | +31.3% |
| Q4 2019 | $317,000 | – | 6,736 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |